Search Results - "Lau, David H. W."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2

    Doxazosin and Serotonin (5-HT) Receptor (1A, 2A, and 4) Antagonists Inhibit 5-HT-Mediated Human Cavernosal Contraction by Lau, David H. W, Thompson, Cecil S, Bellringer, James F, Thomas, Philip J, Mumtaz, Faiz H, Morgan, Robert J, Mikhailidis, Dimitri P

    Published in Journal of andrology (01-09-2006)
    “…Penile erection results from the balance between relaxation and contractile mechanisms of the corpus cavernosum. Only a few studies suggest a role for…”
    Get full text
    Journal Article
  3. 3

    Angiotensin II Increases Corpus Cavernosal Contractility and Oxidative Stress in Partial Bladder Outlet Obstructed Rabbits: Relevance to Erectile Dysfunction by Ertemi, Hani, Lau, David H.W., Mikhailidis, Dimitri P., Mumtaz, Faiz H., Thompson, Cecil S.

    Published in Journal of sexual medicine (01-05-2013)
    “…We investigated the effect angiotensin II (Ang II), a corpus cavernosal smooth muscle (CCSM) constrictor peptide, has on tissue taken from rabbits following…”
    Get full text
    Journal Article
  4. 4

    Gene therapy and erectile dysfunction: the current status by Lau, David H. W., Kommu, Sashi S., Siddiqui, Emad J., Thompson, Cecil S., Morgan, Robert J., Mikhailidis, Dimitri P., Mumtaz, Faiz H.

    Published in Asian journal of andrology (01-01-2007)
    “…Current available treatment options for erectile dysfunction (ED) are effective but not without failure and/or side effects. Although the development of…”
    Get full text
    Journal Article
  5. 5

    Serotonin induces a biphasic response in rabbit cavernosal smooth muscle: relevance to the erectile process by Lau, David H W, Thompson, Cecil S, Mumtaz, Faiz H, Morgan, Robert J, Mikhailidis, Dimitri P

    Published in Urologia internationalis (01-01-2007)
    “…Serotonin (5-hydroxytryptamine; 5-HT) can cause contraction in cavernosal smooth muscle. We further evaluated this effect of 5-HT. Organ bath studies were…”
    Get more information
    Journal Article
  6. 6
  7. 7

    The management of phosphodiesterase-5 (PDE5) inhibitor failure by Lau, David H W, Kommu, Sashi, Mumtaz, Faiz H, Morgan, Robert J, Thompson, Cecil S, Mikhailidis, Dimitri P

    Published in Current vascular pharmacology (01-04-2006)
    “…The oral phosphodiesterase type 5 (PDE5) inhibitors have made a valuable contribution to the treatment of erectile dysfunction (ED). PDE5 inhibitors enhance…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Pharmacological Properties of Endothelin-1 in the Rabbit Corpus Cavernosum by Mumtaz, Faiz H, Lau, David H W, Siddiqui, Emad J, Thompson, Cecil S, Morgan, Robert J, Mikhailidis, Dimitri P

    Published in In vivo (Athens) (01-03-2006)
    “…Background: Endothelin (ET-1) may play a role in the regulation of erection but this has not been conclusively demonstrated. Augmented cavernosal smooth muscle…”
    Get full text
    Journal Article
  12. 12

    Erectile dysfunction: a need for greater awareness by Lau, David H W, Mumtaz, Faiz H, Thompson, Cecil S, Mikhailidis, Dimitri P

    “…Research has led to effective treatment regimes for erectile dysfunction (ED). Convincing evidence links vascular risk factors (hypertension, diabetes…”
    Get full text
    Journal Article